Bleph 10, Sodium Sulamyd (sulfacetamide ophthalmic) dosing, indications, interactions, adverse effects, and more

Sections

Sections sulfacetamide ophthalmic
Dosing & Uses
Adverse Effects
Warnings
Pregnancy
Pharmacology
Images
Patient Handout
Formulary

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

ophthalmic solution

ointment

Conjunctivitis

Solution: 1-3 gtt q2-3hr, taper as condition responds

Ointment 1/2 inch q3-4hr & HS; taper as condition responds

Trachoma

2 gtt q2hr concurrently with systemic therapy

Dosage Forms & Strengths

ophthalmic solution

ointment

Conjunctivitis

< 2 months

Safety & efficacy not established

> 2 months

Solution: 1-3 gtt q2-3hr, taper as condition responds
Ointment 1/2 inch q3-4hr & HS; taper as condition responds

Frequency Not Defined

Hypersensitivity & allergic reactions (rash, etc)

Myopia

Burning conjunctivitis

Conjunctival hyperemia

Corneal ulcers

Irritation

Stinging

Contraindications

Sensitivity to sulfa compounds or other components

Cautions

May result in the overgrowth of nonsusceptible organisms including fungi; bacterial resistance to sulfonamides may also develop

Effectiveness of sulfonamides may be reduced by the para-aminobenzoic acid present in purulent exudates

Discontinue use of medication and consult a physician at first sign of hypersensitivity, increase in purulent discharge, or aggravation of inflammation or pain

Fatalities have occurred, although rarely, due to severe reactions to sulfonamides including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, and other blood dyscrasias

Hypersensitivity reactions may occur when a sulfonamide is readministered, irrespective of the route of administration; sensitivity reactions have been reported in individuals with no prior history of sulfonamide hypersensitivity; at first sign of hypersensitivity, skin rash, or other reactions, discontinue use

Pregnancy & Lactation

Pregnancy Category: C

Lactation: Safety in nursing infants unknown; not recommended

Pregnancy Categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

Mechanism of Action

Interfere with utilization of para-aminobenzoic or para-aminobenzoic glutamic acids by bacteria, thus inhibiting the biosynthesis of folic acid which is essential for the growth of susceptible organisms

Images

No images available for this drug.

Patient Handout

A Patient Handout is not currently available for this monograph.

Formulary

FormularyPatient Discounts

Adding plans allows you to compare formulary status to other drugs in the same class.

To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

Create Your List of Plans

Adding plans allows you to:

View the formulary and any restrictions for each plan.
Manage and view all your plans together – even plans in different states.
Compare formulary status to other drugs in the same class.
Access your plan list on any device – mobile or desktop.

The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

View explanations for tiers and restrictions

Tier	Description
1	This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
2	This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
3	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
4	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
5	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
6	This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
NC	NOT COVERED – Drugs that are not covered by the plan.

Code	Definition
PA	Prior Authorization Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
QL	Quantity Limits Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
ST	Step Therapy Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
OR	Other Restrictions Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.

Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.

[CLOSE WINDOW]